| pubmed-article:16542793 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0521362 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0596790 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0205101 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0006098 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0205480 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C2347880 | lld:lifeskim |
| pubmed-article:16542793 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16542793 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16542793 | pubmed:dateCreated | 2006-5-12 | lld:pubmed |
| pubmed-article:16542793 | pubmed:abstractText | The aim of this retrospective review of patients with gynecologic malignancies treated with external beam radiotherapy (EBRT) and interstitial brachytherapy was to determine the rate of Grade > or =2 rectovaginal fistula and Grade > or =4 small bowel obstruction as defined by the National Cancer Institute Common Toxicity Criteria for Adverse Events, version 3.0. | lld:pubmed |
| pubmed-article:16542793 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16542793 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16542793 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16542793 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16542793 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16542793 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:MontanaGustav... | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:OlesonJames... | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:CloughRobert... | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:LightKimK | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:JonesEllen... | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:KasibhatlaMoh... | lld:pubmed |
| pubmed-article:16542793 | pubmed:author | pubmed-author:SteffeyBeverl... | lld:pubmed |
| pubmed-article:16542793 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16542793 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16542793 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:16542793 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16542793 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16542793 | pubmed:pagination | 398-403 | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:meshHeading | pubmed-meshheading:16542793... | lld:pubmed |
| pubmed-article:16542793 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16542793 | pubmed:articleTitle | Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. | lld:pubmed |
| pubmed-article:16542793 | pubmed:affiliation | Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Hanover, NH 03756, USA. Mohit.S.Kasibhatla@Hitchcock.org | lld:pubmed |
| pubmed-article:16542793 | pubmed:publicationType | Journal Article | lld:pubmed |
